Edition:
United Kingdom

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

7.55USD
22 May 2018
Change (% chg)

$0.05 (+0.67%)
Prev Close
$7.50
Open
$7.54
Day's High
$7.58
Day's Low
$7.50
Volume
22,186
Avg. Vol
334,652
52-wk High
$8.63
52-wk Low
$4.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.19 December 22 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 5.40 7.70 3.30 --
Quarter Ending Sep-18 5 12.06 29.10 4.90 --
Year Ending Dec-18 5 37.01 76.90 21.50 95.27
Year Ending Dec-19 4 90.30 101.80 73.10 127.88
Earnings (per share)
Quarter Ending Jun-18 4 -0.19 -0.16 -0.21 --
Quarter Ending Sep-18 4 -0.01 0.09 -0.11 --
Year Ending Dec-18 5 -0.57 -0.10 -0.79 -0.05
Year Ending Dec-19 3 -0.04 0.06 -0.14 0.39

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 4.35 3.19 1.16 26.69
Quarter Ending Dec-17 3.20 3.89 0.69 21.53
Quarter Ending Sep-17 3.52 2.70 0.82 23.38
Quarter Ending Jun-17 3.67 2.77 0.91 24.76
Quarter Ending Mar-17 4.49 2.35 2.15 47.75

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5.40 5.40 6.03 6.65 --
Quarter Ending Sep-18 12.06 12.06 13.72 13.72 --
Year Ending Dec-18 37.01 37.01 38.59 42.54 95.27
Year Ending Dec-19 90.30 90.30 87.93 87.93 127.88

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 1
Quarter Ending Sep-18 0 0 0 1
Year Ending Dec-18 0 0 0 2
Year Ending Dec-19 0 0 1 1
Earnings